Fewer Deaths in Diabetes Patients Given Drug-Eluting Stents

NEW ORLEANS — Diabetes patients treated with drug-eluting stents showed impressive reductions in mortality, acute myocardial infarction, and repeat revascularization during the subsequent 3 years compared with bare-metal stent recipients in a large real-world Massachusetts registry featuring mandatory reporting and follow-up.